학술논문

A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer
Document Type
Article
Source
In: Investigational New Drugs. (Investigational New Drugs, 1 June 2018, 36(3):458-467)
Subject
Language
English
ISSN
15730646
01676997